We hypothesized that unlike nitric oxide (NO)-agents, L-NAME and/or L-arginine, the application of the stable gastric pentadecapeptide BPC 157 with its most recent vascular effects (vascular recruitment) means attenuated bowel adhesion formation and NO- and malondialdehyde (MDA)-tissue values
A reader who understands the actual structural problem can ask better questions of any unpatentable therapeutic, and tell promising-but-untrialled apart from suppressed-but-proven
Dont take the chance, its not worth it
Evidence within human hypertension is limited, with several indirect biomarkers that are purported to be indicators of gut permeability increased in participants with hypertension
What concerns me is what happens when you chronically stimulate these pathways in the brain
Citations [1] Sun X, Deng Y, Fu X, Wang S, Duan R, Zhang Y